首页> 外文期刊>The veterinary clinics of North America: small animal practice >The Use of NT-proBNP Assay in the Management of Canine Patients with Heart Disease
【24h】

The Use of NT-proBNP Assay in the Management of Canine Patients with Heart Disease

机译:NT-proBNP分析在犬心脏病患者管理中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

The diagnosis and management of canine heart disease could be facilitated by a highly sensitive and specific laboratory test that predicts risk of morbidity and mortality, is helpful in directing therapy, easy to perform, inexpensive, and widely available This article details if, how, and when the cardiac biomarker, N-terminal fragment of the prohormone B-type natriuretic peptide (NT-proBNP), helps in the diagnosis and management of canine heart disease. Veterinary cardiac biomarkers, specifically NT-proBNP, hold great promise. The incorporation of NT-proBNP assay into successful clinical practice requires an understanding of the science behind the technology, as well as the clinical data available to date
机译:可以通过高度灵敏,特异的实验室测试来促进犬心脏病的诊断和治疗,该实验室测试可以预测发病和死亡的风险,有助于指导治疗,易于执行,价格低廉且可广泛使用。本文详细介绍了是否,如何以及当心脏生物标志物时,激素原B型利钠肽(NT-proBNP)的N端片段有助于犬心脏病的诊断和治疗。兽医心脏生物标志物,特别是NT-proBNP,具有广阔的前景。将NT-proBNP分析纳入成功的临床实践需要了解该技术背后的科学知识,以及迄今为止可获得的临床数据

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号